Sherrica Tai
Affiliations: | 2014-2016 | Pharmacology and Toxicology | University of Arkansas for Medical Sciences, United States |
Google:
"Sherrica Tai"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ford BM, Cabanlong CV, Tai S, et al. (2019) Reduced tolerance and asymmetrical cross-tolerance to effects of indole quinuclidinone analogue PNR-4-20, a G protein biased CB1R agonist in mice: comparisons with Δ9-THC and JWH-018. The Journal of Pharmacology and Experimental Therapeutics |
| Wilson CD, Tai S, Ewing L, et al. (2018) Convulsant effects of abused synthetic cannabinoids JWH-018 and 5F-AB-PINACA are mediated by agonist actions at CB1 receptors in mice. The Journal of Pharmacology and Experimental Therapeutics |
| Tai S, Vasiljevik T, Sherwood AM, et al. (2018) Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice. Drug and Alcohol Dependence. 192: 285-293 |
| McPherson KB, Leff ER, Li MH, et al. (2018) Regulators of G protein Signaling (RGS) proteins promote receptor coupling to G protein-coupled inwardly-rectifying potassium (GIRK) channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Ford BM, Franks LN, Tai S, et al. (2017) Characterization of Structurally Novel G Protein Biased CB1 Agonists: Implications for Drug Development. Pharmacological Research |
| Ford BM, Tai S, Fantegrossi WE, et al. (2017) Synthetic Pot: Not Your Grandfather's Marijuana. Trends in Pharmacological Sciences |
| Tai S, Fantegrossi WE. (2016) Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites. Current Topics in Behavioral Neurosciences |
| Tai S, Hyatt WS, Gu C, et al. (2015) Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner. Pharmacological Research. 102: 22-32 |
| Tai S, Nikas SP, Shukla VG, et al. (2015) Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology. 232: 2751-61 |
| Tai S, Fantegrossi WE. (2014) Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. Current Addiction Reports. 1: 129-136 |